United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 14, 2026 · Filed May 15, 2026

On May 14, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$574.48 for US$5.46M under a trading plan, leaving 40,513 shares. Filed May 15, 2026 (Form 4).

Sold
9,500 shares
Price
US$574.48 average (US$568.69 to US$578.29)
Value
US$5.46M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 14, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 14, 2026Common StockSale40US$568.6949,973Direct
May 14, 2026Common StockSale376US$571.0449,597Direct
May 14, 2026Common StockSale560US$572.0449,037Direct
May 14, 2026Common StockSale744US$572.9048,293Direct
May 14, 2026Common StockSale3,283US$574.2145,010Direct
May 14, 2026Common StockSale2,922US$575.0242,088Direct
May 14, 2026Common StockSale983US$575.9841,105Direct
May 14, 2026Common StockSale232US$576.8840,873Direct
May 14, 2026Common StockSale360US$578.2940,513Direct

Source

View original at SEC

Related